The activation of the G protein‐coupled receptor RXFP1 by RLN2 or CTRP8 has been associated with enhanced tumor cell motility and tissue invasion in several tumors, but the underlying molecular mechanisms remain poorly understood [55, 73, 74, 75, 76, 77, 78]. This evidence concerns the gene RLN2 and neoplasm.